The Enterprise Value as of December 2025 (TTM) for Elicio Therapeutics, Inc. (ELTX) is 128.40M

According to Elicio Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 128.40M. This represents a change of 21.71% compared to the average of 105.50M of the last 4 quarters.

Elicio Therapeutics, Inc. (ELTX) Historical Enterprise Value (quarterly & annually)

How has ELTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Elicio Therapeutics, Inc. over the last ten years is 32.85M. The current 128.40M Enterprise Value has changed 38.99% with respect to the historical average. Over the past ten years (40 quarters), ELTX's Enterprise Value was at its highest in in the September 2025 quarter at 167.34M. The Enterprise Value was at its lowest in in the June 2021 quarter at -98990181.52.

Elicio Therapeutics, Inc. (ELTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Elicio Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Elicio Therapeutics, Inc. (ELTX) Average Enterprise Value

How has ELTX Enterprise Value performed in the past?

The current Enterprise Value of Elicio Therapeutics, Inc. (ELTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Elicio Therapeutics, Inc. (ELTX) Enterprise Value vs. Peers

How is ELTX’s Enterprise Value compared to its peers?

Elicio Therapeutics, Inc.’s Enterprise Value is greater than Applied Therapeutics, Inc. (23.64M), greater than Corbus Pharmaceuticals Holdings, Inc. (116.42M), greater than Molecular Partners AG (45.15M), less than Cardiff Oncology, Inc. (136.29M), greater than Rani Therapeutics Holdings, Inc. (123.77M), less than Milestone Pharmaceuticals Inc. (235.37M), less than PepGen Inc. (347.79M), less than Nkarta, Inc. (155.82M), greater than Cassava Sciences, Inc. (48.00M), less than Actuate Therapeutics Inc (153.91M),

Build a custom stock screener for Elicio Therapeutics, Inc. (ELTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Elicio Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Elicio Therapeutics, Inc. (ELTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Elicio Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.